1.天津中医药大学,天津市静海区团泊新城西区鄱阳湖路10号,301617
2.天津市中医药研究院附属医院
15522004092@163.com
收稿:2023-11-19,
修回:2024-03-04,
纸质出版:2024-07-02
移动端阅览
包文辉,张曾譻.基于精明失养辨治桥本甲状腺炎[J].中医杂志,2024,65(13):1399-1402.
BAO Wenhui,ZHANG Zengying.Diagnosis and Treatment of Hashimoto's Thyroiditis Based on Loss of Nourishment in Bright Essence[J].Journal of Traditional Chinese Medicine,2024,65(13):1399-1402.
包文辉,张曾譻.基于精明失养辨治桥本甲状腺炎[J].中医杂志,2024,65(13):1399-1402. DOI: 10.13288/j.11-2166/r.2024.13.015.
BAO Wenhui,ZHANG Zengying.Diagnosis and Treatment of Hashimoto's Thyroiditis Based on Loss of Nourishment in Bright Essence[J].Journal of Traditional Chinese Medicine,2024,65(13):1399-1402. DOI: 10.13288/j.11-2166/r.2024.13.015.
总结基于精明失养辨治桥本甲状腺炎的临证经验。认为桥本甲状腺炎的关键病机为七情所伤、精明失养,提出以健脑宁心为治疗总则。针对桥本甲状腺炎合并甲状腺功能减退,选用自拟方甲安合剂加减,以健脑宁心、柔肝滋肾;桥本甲状腺炎合并甲状腺功能亢进,选用自拟方心脑康加减,以健脑宁心、益气活血通络;桥本甲状腺炎合并甲状腺结节,选用自拟方消癖舒加减,以益气养阴、活血散结。
To summar
ize the clinical experience of the diagnosis and treatment of Hashimoto's thyroiditis based on the theory of "loss of nourishment in bright essence". It is believed that damages of the seven emotions and loss of nourishment in bright essence are the root cause of Hashimoto's thyroiditis, so the overall therapeutic principle was proposed as fortifying brain and tranquillizing mind. For patients with Hashimoto's thyroiditis combined with hypothyroidism, the self-prescribed
Jiaan Mixture Formula
(甲安合剂) with modification is used to fortify brain and tranquillize mind, emolliate the liver and nourish the kidneys; for patients with Hashimoto's thyroiditis combined with hyperthyroidism, the self-prescribed
Xinnao Kang Formula
(心脑康) with modification is used to fortify brain and tranquillize mind, boost
qi
, invigorate blood, and unblock the collaterals; and for patients with Hashimoto's thyroiditis combined with nodularity, the self-prescribed
Xiaopi Shu Formula
(消癖舒) with modification is used to boost
qi
and nourish
yin
, and invigorate blood and dissipate masses.
PYZIK A , GRYWALSKA E , MATYJASZEK-MATUSZEK B , et al . Immune disorders in Hashimoto's thyroiditis: what do we know so far? [J]. J Immunol Res , 2015 , 2015 : 979167 . doi: 10.1155/2015/979167 http://dx.doi.org/10.1155/2015/979167 .
ANTONELLI A , FERRARI S M , CORRADO A , et al . Autoimmune thyroid disorders [J]. Autoimmunity Reviews , 2015 , 14 ( 2 ): 174 - 80 .
OTT J , MEUSEL M , SCHULTHEIS A , et al . The incidence of lymphocytic thyroid infiltration and Hashimoto's thyroiditis increased in patients operated for benign goiter over a 31-year period [J]. Virchows Arch , 2011 , 459 ( 3 ): 277 - 81 .
HIROMATSU Y , SATOH H , AMINO N . Hashimoto's thyroiditis: history and future outlook [J]. Hormones (Athens, Greece) , 2013 , 12 ( 1 ): 12 - 8 .
AJJAN RA , WEETMAN AP . The Pathogenesis of Hashimoto's thyroiditis: further developments in our understanding [J]. Horm Metab Res , 2015 , 47 ( 10 ): 702 - 10 .
CHEN WH , CHEN YK , LIN CL , et al . Hashimoto's thyroiditis, risk of coronary heart disease, and L-thyroxine treatment: a nationwide cohort study [J]. J Clin Endocrinol Metab , 2015 , 100 ( 1 ): 109 - 14 .
RAGUSA F , FALLAHI P , ELIA G , et al . Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy [J]. Best Pract Res Clin Endocrinol Metab , 2019 , 33 ( 6 ): 101367 .
RALLI M , ANGELETTI D , FIORE M , et al . Hashimoto's thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation [J]. Autoimmun Rev , 2020 , 19 ( 10 ): 102649 .
WEETMAN AP . An update on the pathogenesis of Hashimoto's thyroiditis [J]. J Endocrinol Investigat , 2021 , 44 ( 5 ): 883 - 90 .
王文礼 , 刘冉 . 中医药治疗桥本甲状腺炎临床研究进展 [J]. 中医药临床杂志 , 2023 , 35 ( 5 ): 1031 - 1035 .
迪娜·塔吾列 , 温伟波 . 桥本甲状腺炎的中医研究进展 [J]. 云南中医中药杂志 , 2019 , 40 ( 5 ): 78 - 80 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号